AI

Atlantis Investment Management

Asia, Hong Kong Island, Hong Kong, Central

Description

Atlantis Investment Management specializes in providing equity strategies.

Investor Profile

Atlantis Investment Management has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (50%)
  • Convertible Note (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Pharmaceutical
  • Advanced Materials
  • Health Diagnostics
  • Biopharma
  • Biotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Atlantis Investment Management frequently co-invest with?

CMBC Capital Holdings
Asia, Kowloon, Hong Kong, Jordan
Co-Investments: 1
Pangaea Ventures
North America, Arizona, United States, Phoenix
Co-Investments: 1
BVCF
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Co-Investments: 1
Happiness Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
OE
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Sagamore Investments
Asia, Beijing, China, Beijing
Co-Investments: 1
Presidio Ventures
North America, California, United States, Santa Clara
Co-Investments: 1
Pivotal bioVenture Partners
North America, California, United States, San Francisco
Co-Investments: 1
Kingdon Capital
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Atlantis Investment Management?

TruTag Technologies

Emeryville, California, United States

TruTag Technologies, Inc. provides product authentication and brand protection solutions.

Advanced MaterialsHealth DiagnosticsPharmaceutical
Series COct 17, 2019
Amount Raised: $33,571,000
Stealth BioTherapeutics

Newton, Massachusetts, United States

Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Convertible NoteJun 18, 2018
Amount Raised: $100,000,000